CQ Medical announced the acquisition of .decimal, a manufacturer of patient-specific beam shaping devices and advanced technologies used in cancer treatment.
Serving the radiotherapy clinical community for more than 40 years, .decimal is known for its rapid production of customized, patient-specific devices—typically manufactured and shipped within 1–2 days of order receipt. To date, the company has delivered more than 500,000 patient-specific treatment devices, and actively serves more than 900 cancer centers across the United States.
CQ Medical was formed in 2022 through the combination of CIVCO Radiotherapy and Qfix. The CQ Medical portfolio covers a range of clinical applications, including devices for precision stereotactic treatment and proton therapy, implantable fiducial markers for image-guided radiotherapy, customizable thermoplastic patient immobilization, and patient transfer systems for radiotherapy and interventional cardiology & radiology procedures.
The addition of .decimal's product lines strengthens CQ Medical's portfolio of essential radiotherapy consumables and expands its ability to meet the specialized needs of clinical partners. The acquisition also enhances CQ Medical's manufacturing and technology capabilities, enabling future innovation through integration with .decimal's software platform and specialized production expertise.
Following the acquisition, .decimal's operations will continue from its Sanford, Florida facility, ensuring continuity of service, quality, and support for customers.
